IP Library › Granted Patent US 7,662,777
Granted Patent B2
US 7,662,777 · App. 11/569,095 · Granted Feb 16, 2010

Use of sulglicotide for the treatment of mucositis

Assignee: Gentium SpA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,662,777
App. No.
11/569,095
Granted
Feb 16, 2010
Kind
B2
Abstract

A method for the treatment and/or prevention of mucositis due to an antitumour treatment which comprises the administration of a composition containing suiglicotide to a patient in needs of said antitumour treatment.

Claims (6)

1. A method for the treatment and/or reduction of oral mucositis due to an antitumor treatment which comprises the administration of a composition consisting essentially of sulglicotide to a patient receiving said antitumour treatment.

2. A method according to claim 1 in which the antitumour treatment is chemotherapy and/or radiotherapy.

3. A method according to claim 1 in which the sulglicotide is administered in a quantity of from 12.5 mg/kg to 800 mg/kg.

4. A method according to claim 1 in which said compositions are topical dosage forms.

5. A method according to claim 1 in which said pharmaceutical compositions are oral dosage forms.

6. A method according to claim 1 in which said compositions are parenteral dosage forms.

Assignments (2)
CHANGE OF NAME Recorded Oct 11, 2016
From: GENTIUM S.P.A.
To: GENTIUM S.R.L.
Reel/Frame 040314/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2007
From: IACOBELLI, MASSIMO; FERRO, LAURA IRIS
To: GENTIUM SPA
Reel/Frame 019041/0972 →
Priority Claims (1)
IT MI2004A0989 · May 18, 2004 · national
Continuity (1)
Related Publication 20080234180A1 · Sep 25, 2008